Man Group PLC Arrowhead Pharmaceuticals, Inc. Transaction History

Man Group PLC

$36 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$27.21 - $39.48 $2.74 Million - $3.98 Million	-100,842 Reduced 89.27%	12,117 $346,000
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $2.17 Million - $3.17 Million	102,124 Added 942.54%	112,959 $3.46 Million
Q3 2023 Nov 14, 2023	BUY	$26.2 - $36.08 $283,877 - $390,926	10,835 New	10,835 $291,000
Q1 2023 May 15, 2023	SELL	$23.68 - $38.51 $26,758 - $43,516	-1,130 Reduced 2.89%	38,025 $965,000
Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $1.1 Million - $1.59 Million	39,155 New	39,155 $1.59 Million
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $120,664 - $219,748	-4,342 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$39.62 - $69.97 $172,030 - $303,809	4,342 New	4,342 $200,000
Q1 2021 May 17, 2021	SELL	$61.35 - $90.47 $1.53 Million - $2.26 Million	-24,971 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $15,249 - $29,708	-348 Reduced 1.37%	24,971 $1.92 Million
Q3 2020 Nov 16, 2020	SELL	$33.21 - $51.27 $4.22 Million - $6.52 Million	-127,099 Reduced 83.39%	25,319 $1.09 Million
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $2.48 Million - $4.11 Million	94,904 Added 165.01%	152,418 $6.58 Million
Q1 2020 May 15, 2020	SELL	$20.56 - $63.12 $3.09 Million - $9.48 Million	-150,135 Reduced 72.3%	57,514 $1.66 Million
Q4 2019 Feb 18, 2020	BUY	$28.14 - $73.01 $2.5 Million - $6.48 Million	88,725 Added 74.61%	207,649 $13.2 Million
Q3 2019 Nov 14, 2019	BUY	$26.26 - $34.86 $2.59 Million - $3.44 Million	98,670 Added 487.16%	118,924 $3.35 Million
Q2 2019 Aug 14, 2019	BUY	$17.43 - $28.82 $353,027 - $583,720	20,254 New	20,254 $537,000
Q4 2018 Feb 14, 2019	SELL	$10.74 - $19.7 $180,270 - $330,664	-16,785 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.0 - $20.3 $75,712 - $109,782	5,408 Added 47.53%	16,785 $322,000
Q2 2018 Aug 14, 2018	BUY	$6.37 - $14.02 $72,471 - $159,505	11,377 New	11,377 $155,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.08B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account